Medytox, “Daewoong should not distort essence of the trial”

Published: 2017-10-27 15:52:03

Updated: 2017-10-27 15:52:03

Medytox(CEO Hyun-Ho Jung) strongly argued an essence of the trial involving the company and Daewoong Pharmaceutical is to reveal the truth if Daewoong Pharmaceutical pirated the company’s botulinum strain and manufacturing process and said not to distort it.

Medytox argued Daewoong Pharmaceutical raised a doubt about the Medytox’s source of strains through a press release on the 25^th of Octobe...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.